CCN3 and CCN3 peptides and analogs thereof for therapeutic use
View Patent ↗The present invention provides a method for treating a human patient with a pathology by administering to the subject an effective amount of an agent selected from the group of: native full-length CCN3 proteins; analog CCN3 full-length proteins with native cysteine residues substituted by a replacement amino acid; CCNp native peptide fragments having from about 12 to about 20 amino acids; analog CCNp peptide fragments with native cysteine residues substituted with a replacement amino acid; and combinations thereof.
1. A peptide comprising a sequence selected from the group consisting of SEQ ID NOs: 39, 40, 59, 60, 61, and 62.
2. A peptide comprising a sequence selected from the group consisting of SEQ ID NOs: 36-40, 42, 53-62, and combinations thereof.